H1 FY2025 Results Presentation
Released
Released
Announcement PDF
H1 -25 Results Presentation
29August 2025
Disclaimer
This presentation has been prepared by Elixinol Wellness Limited (Company). It contains general background information only which is current at the date of this presentation unless otherwise specified. It contains selected
summary information and does not purport to be all-inclusive, comprehensive or contain all information that may be relevant, or which a prospective investor may require in evaluating a possible investment in the
Company. Prospective investors should not rely on the information contained in this presentation and must satisfy themselves as to the accuracy of all such information. This presentation has been prepared based on
information available at the time of preparation and is subject to change without notice.
This presentation is provided for general information purposes only. It does not constitute an offer, invitation, solicitation or recommendation with respect to the purchase or sale of securities in the Company in any
jurisdiction. It is not a prospectus, product disclosure statement, pathfinder document or any other type of public offer disclosure document for the purposes of the Corporations Act 2001 (Cth) and has not been, and is not
required to be, lodged with the Australian Securities and Investments Commission (ASIC). It should not be relied on by the recipient in considering the merits of the Company, or the acquisition of shares in the Company.
None of Elixinol Wellness, its subsidiaries nor its representatives make any representation, warranty or guarantee of any kind, express or implied, as to the accuracy, completeness or reasonableness of the information
contained herein or any other written or oral communication transmitted or made available to any person receiving this presentation. To the maximum extent permitted by law, Elixinol, its subsidiaries and representatives
expressly disclaim all liability based on or arising from, in whole or in part, such information, or any errors or omissions.
This presentation contains forward-looking statements regarding the Company’s resources, intentions and future business, including the future business of its subsidiaries. These statements reflect current information,
expectations, intentions and strategies regarding the future, and are subject to certain risks and uncertainties. Should one or more of these risks or uncertainties materialise, or should any of the underlying assumptions prove
incorrect, actual results may vary from the expectations, intentions and strategies described in this presentation. Investors are cautioned not to place undue reliance on forward-looking statements, which speak only as of
the date they are made. Other than where required by law, the Company is under no obligation to revise any forward-looking statement to reflect events or circumstances after the date of this presentation or to reflect the
occurrence of unanticipated events.
Though reasonable care has been taken to ensure that the facts are accurate and that the opinions expressed are fair and reasonable, no reliance can be placed for any purpose whatsoever on the information contained in
this document or on its completeness. Actual results and the market development may differ materially from those expressed or implied by these forward-looking statements depending on a variety of factors.
This Presentation is current as of 29 August 2025.
2
H1-25 Scorecard
Sales Growth
Margin Improvement
•
Revenue up 12.8% (H1-25 $7.6m, H1-24: $6.8m)
•
H1-25 gross margin 37% (35% H1-24)
•
Healthy Chef: strong Q2, H1-25 revenue $1.7m
•
•
HFA: core hemp business stabilised (H1-25 $2.4m)
Retail brands’ cost pressures (hemp grain,
chocolate) offset by ecommerce margins
•
Mt Elephant: return to growth in Q2 vs Q1-2025
•
Q2 -25 gross margin (38%), procurement
improvements to underwrite further gains
Ops. Optimisation
Channel Diversification
•
•
E-commerce growth in H1 reduced the risk of
reliance on traditional retail
Grocery and bulk channels experienced organic
growth in Q2 vs Q1-2025
•
Ananda NSW facility closed in March
•
Soul Seeds hemp products consolidated under
Hemp Foods
•
Cost reduction measures to reduce cash burn as
one-off costs also begin to fall away
3
Financial Highlights
Group Revenue ($M)
+0.8
Revenue Growth
(12.8%)
•
Australia’s House of Brands (incl. Healthy Chef) drove 12.8%
YoY growth in H1-25.
6.8
•
H1 impacted by seasonality, with sales lower vs H2-24.
•
Elixinol Americas revenue softened as marketing scaled back
ahead of rebrand and digital overhaul
5.8
1.0
H1-24
8.2
7.6
7.1
6.8
1.1
H2-24
0.8
H1-25
Australia
Americas
Adjusted EBITDA
•
Loss widened to –$2.2m (H1-24: –$1.5m; H2 -24: –$1.2m)
•
Integration of acquisitions increased costs; optimisation
benefits to flow in H2
Adjusted* EBITDA ($M)
•
Margin pressures from ingredient costs and lower seed yields
offset by Healthy Chef’s higher-margin portfolio
•
Rationalisation underway, paving the path to profitability
-1.5
-1.2
-2.2
H1-24
H2-24
H1-25
*Adjusted to exclude non-cash impairments, share-based payments and non-recurring expenses
4
Profit and Loss Snapshot
Revenue
Revenue
H1-25
$(M)
7.6
H1-24
$(M)
6.8
Cost of goods sold
(4.8)
(4.4)
Gross Profit
2.8
2.4
GP Margin (%)
37%
35%
Operating expenses
(5.7)
(4.1)
Non-operating income
0.7
0.2
Adjusted* EBITDA
(2.2)
(1.5)
Depreciation
(0.5)
(0.5)
Impairment of assets
(0.3)
(0.1)
Share-based payments
0.1
(0.2)
Non-recurring expenses
0.1
(0.3)
Adjusted EBITDA
Interest income/(cost)
(0.3)
(0.1)
Profit/(loss) before tax
(3.1)
(2.8)
•
-
-
Adjusted EBITDA loss of –$2.2m, with cost base transition and
optimisation still underway
(3.1)
(2.8)
•
Procurement gains, ongoing rationalisation and integration synergies
expected to improve H2 trajectory
Tax expense
Profit/(loss) after tax
*Adjusted to exclude non-cash impairments, share-based payments and nonrecurring expenses
•
Revenue up 12.8% YoY to $7.6m, led by House of Brands expansion
following Healthy Chef acquisition
Margins
•
Gross margin lifted to 37% (vs 35%), supported by higher e-commerce
mix
•
Ingredient cost pressures (hemp grain, chocolate) impacted margins
but are resolved for H2
Operating Expenses
•
Higher Op Ex ($5.7m vs $4.1m) driven by integration of Healthy Chef
operating costs and Ananda operations closing end Q1
5
Segment Performance
Australia
A$M
H1 25
Revenue
Gross profit
GP%
Op. expenses
Other income
Adjusted EBITDA*
6.8
2.3
33%
(3.7)
(1.4)
Americas
Corporate
H1 24
H1 25
H1 24
H1 25
H1 24
5.8
1.7
30%
(2.4)
(0.7)
0.8
0.6
69%
(0.9)
0.2
(0.1)
1.0
0.6
64%
(0.7)
0.2
0.1
(0.7)
(0.7)
(0.9)
(0.9)
* Adjusted to exclude non-cash impairments, share-based payments and non-recurring expenditure
Sales Channel Mix
Shifting towards higher margin E-Commerce
15%
2025
38%
48%
Other includes Bulk and Private Label
E-commerce
21%
Retail
Other
19%
2024
Australia
•
Revenue up $1.0M, driven by Healthy Chef acquisition;
base brands softer in Q1 but rebounded Q2
•
Gross profit lifted to 33% with higher-margin ecommerce mix
•
Op Ex increased following acquisitions and dual
facilities; Newcastle facility closed in H1
Americas
•
Revenue $0.8m (vs $1.0m), reflecting transition to ecommerce model
•
Margin grew to 69% (vs 64%) prioritising higher
margin products
Sales Mix
•
E-commerce mix rose to 38% (vs 21%), reducing
reliance on lower-margin retail
59%
6
Financial Position
Current assets
Cash and cash equivalents
Trade & other receivables
Inventories
Assets held for sale
Other
Total current assets
Non-current assets
Property, plant and equipment
Intangible assets
Deferred Tax Asset
Other
Total non-current assets
Total assets
Liabilities
Trade and other payables
Borrowings
Other current liabilities
Contingent Consideration
Other Non-current liabilities
Total liabilities
Net assets
30 Jun
2025
($M)
31 Dec
2024
($M)
1.1
1.3
2.9
0.2
0.5
1.1
1.6
3.9
0.6
0.8
6.0
3.6
0.2
10.6
1.2
6.2
3.6
0.3
11.3
6.0
7.2
16.6
18.5
2.2
2.5
1.8
2.6
0.5
9.6
7.0
2.2
1.1
1.7
2.7
0.7
8.4
10.0
Working Capital
•
Receivables reduced with stronger collections
•
Inventory down ($3.9m → $2.9m) through improved
turns and purchasing discipline
•
Trade and Other Payables steady
•
Significant improvement in the Cash Conversion Cycle
Borrowings
•
Borrowings increased to $2.5m following $1.3m debt
funding
Contingent consideration
•
$2.6m liability relates to Healthy Chef acquisition
Discipline to drive recovery
•
Net assets at $7.0m (Dec-24: $10.0m) reflecting focus on
working capital reduction
7
H1 FY25 Cash Flow
H1 25
$(M)
H1 24
$(M)
Cashflow from operating activities
(1.4)
(2.1)
Cashflow from investing activities
0.0
0.4
Cashflow from financing activities
1.4
2.6
Net increase/(decrease) in cash
0.0
0.9
Opening cash and cash equivalents
1.1
0.7
FX impact
-
-
Closing cash on hand
1.1
1.6
Net Cashflow
•
•
•
Neutral cashflow: financing inflows balanced
operating outflows
Operating Cash Flow
•
•
Cash burn reduced to –$1.4m (H1 -24: –$2.1m)
Improvement from lower losses (+$0.4m) and insurance
proceeds (+$0.5m), partly offset by finance costs
+0.8
-1.4
-2.1
0.5
Closing cash $1.1m (H1-24: $1.6m)
H2 focus on cash discipline and operational
efficiency for long term growth
-0.1
0.4
H1 24
Lower
Losses
Insurance
Proceeds
Finance
cost
H1 25
8
H2 FY25 Growth Strategy
H2 25 and Beyond
Profitability
Sustained Growth
•
Revenue up 12.8% YoY in H1-25; with stronger uplift
expected in H2-25 from Q4-25 e-commerce peak
•
•
Healthy Chef protein waters and GLP-1 launches to
accelerate growth
Gross margin lifted and stabilised in H1-25,
expected to further improve in H2-25
•
Q4-25 profitability targeted, with sustainable
EBITDA run-rate into 2026
•
Mt Elephant and Soul Seed range reset positions
brands for retail expansion
•
Strategic product and customer margin review to
support sustained profitability
Operational Leverage
Channels & Markets
•
Innovative launches planned for H2-25 to further
drive e-commerce growth
•
•
Retail growth to be reignited through innovation and
refreshed ranging
Business simplification and right-sizing to be
completed during H2-25
•
Final Integration costs fall away from H2-25
•
Elixinol US brand and digital strategy refresh
underway
•
Operating expenses to increase at a slower rate
than revenues to improve profitability
10
Thank you!
Share your feedback
Discover